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A B S T R A C T
The transcription factors GATA4, GATA5 and GATA6 are important regulators of heart muscle diﬀerentiation
(cardiomyogenesis), which function in a partially redundant manner. We identiﬁed genes speciﬁcally regulated
by individual cardiogenic GATA factors in a genome-wide transcriptomics analysis. The genes regulated by
gata4 are particularly interesting because GATA4 is able to induce diﬀerentiation of beating cardiomyocytes in
Xenopus and in mammalian systems. Among the speciﬁcally gata4-regulated transcripts we identiﬁed two SoxF
family members, sox7 and sox18. Experimental reinstatement of gata4 restores sox7 and sox18 expression, and
loss of cardiomyocyte diﬀerentiation due to gata4 knockdown is partially restored by reinstating sox7 or sox18
expression, while (as previously reported) knockdown of sox7 or sox18 interferes with heart muscle formation.
In order to test for conservation in mammalian cardiomyogenesis, we conﬁrmed in mouse embryonic stem cells
(ESCs) undergoing cardiomyogenesis that knockdown of Gata4 leads to reduced Sox7 (and Sox18) expression
and that Gata4 is also uniquely capable of promptly inducing Sox7 expression. Taken together, we identify an
important and conserved gene regulatory axis from gata4 to the SoxF paralogs sox7 and sox18 and further to
heart muscle cell diﬀerentiation.
1. Introduction
Heart development and particularly heart muscle diﬀerentiation
(cardiomyogenesis) is controlled by an intricate Gene Regulatory
Network (GRN). This GRN involves prominent members of speciﬁc
transcription factor gene families, such as the Nkx2, Mef2, Tbx and
Gata gene families (Harvey and Rosenthal, 1999; Olson and Srivastava,
1996). Among these important transcription factors, GATA4, GATA5
and GATA6 are identiﬁed as the cardiogenic gata transcription factors
(e.g. Peterkin et al., 2005). GATA4 is particularly important as a potent
driver of cardiomyogenesis. In fact, carefully stage-controlled experi-
mental activation of ectopically expressed GATA4 alone is suﬃcient to
induce diﬀerentiation of functionally beating cardiomyocyte tissue
from pluripotent stem-cell-like Xenopus animal cap explants (Afouda
et al., 2008; Latinkic et al., 2003, see also below, e.g. Fig. 3).
Experimentally forced expression of Gata4 in mouse together with
Tbx5 and the chromatin remodelling protein Baf60c can reprogram
somatic mesoderm into heart muscle cells (Takeuchi and Bruneau,
2009); and combined expression of Gata4 with Tbx5 and Mef2c was
reported to convert cultured ﬁbroblastic cells into a cardiac lineage
(Ieda et al., 2010).
Gata4 but also its paralogs Gata5 and Gata6 are required for normal
heart formation in mammals (reviewed by Nemer, 2008) and human
congenital cardiomyopathies are linked to mutations in the GATA4 gene,
including valve and septal defects (Garg et al., 2003; Rajagopal et al.,
2007). However, Gata4, Gata5 and Gata6 have redundant functions as
demonstrated by studies in mice embryos: Gata4 and Gata6 double
mutants have complete acardia (Zhao et al., 2008), compound Gata4/
Gata5 mutants present severe cardiac defects (Singh et al., 2010) and
compounds Gata4/Gata5 as well as Gata5/Gata6 mutants die embry-
onically or perinatally due to severe cardiac defects (Laforest and Nemer,
2011). Single Gata5 or single Gata6 both have milder phenotypes, though
lack of Gata5 in mice leads to bicuspid aortic valve formation (Laforest
et al., 2011), asserting its importance for mammalian heart formation.
There is a signiﬁcant degree of conservation of the molecular
pathways involved in vertebrate heart formation; studies in zebraﬁsh
have identiﬁed that, in addition to cardia biﬁda, gata5 mutants (also
known as faust) show loss of cardiomyocytes (Holtzinger and Evans,
2007; Reiter et al., 1999). Studies in both zebraﬁsh and Xenopus laevis
have conﬁrmed that gata5 and gata6 have indeed redundant functions
in cardiac progenitor speciﬁcation (Haworth et al., 2008; Holtzinger
and Evans, 2007; Peterkin et al., 2007).
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Taken together, these observations conﬁrm that the cardiogenic
Gata factors represent genes with related function. In fact they derive
through whole-genome duplications during the early vertebrate evolu-
tion (Dehal and Boore, 2005; Gillis et al., 2009; Ohno et al., 1968) from
the same invertebrate ancestral gene (Ragkousi et al., 2011). This
evolutionary origin reinforces the need to address questions about
redundancy and unique functions of these cardiogenic gata transcrip-
tion factors, since these genes may have partitioned an originally
shared function (subfunctionalisation) or some of them may have
acquired new speciﬁc functions (neofunctionalisation). Deciphering the
genetic programme controlled by gata factors is therefore challenging,
yet understanding the redundant and non-redundant speciﬁc function
will be of great beneﬁt for our understanding of heart development. We
had previously uncovered some diﬀerent requirements of cardiogenic
gata factors for Xenopus cardiomyogenesis (Afouda and Hoppler,
2011). A more detailed understanding of the regulatory circuity
controlled by individual cardiogenic gata factors will shed more light
on the complex GRN that drive cardiomyogenesis.
Fig. 1. Activin-induced cardiac explants as cardiogenic assay to screen for genes speciﬁcally regulated by cardiogenic gata genes. Activin-injected animal caps from myl2-GFP reporter
Xenopus laevis transgenic line were cultured until stage 45 and photographed in bright ﬁeld (A) or with GFP ﬁlter (B) allowing visualisation of myl2-expressing cells throughout the
beating explant. Total RNA was extracted from stage 32 wild-type Xenopus laevis explants injected with either Activin (Act) alone or together with gata4, 5 or 6 morpholinos (MOs) for
real-time RT-PCR monitoring of myl2 (C) or tnni3 (D) expression. Following validation, samples were subjected to high-throughput sequencing where (E) represents schematic pipeline
of RNA-seq bioinformatics analysis and (F, H) Venn diagrams of numbers of genes that are diﬀerentially expressed compared to Activin-injected control with at least a two-fold
reduction in expression and an adjusted p value of < 0.05. (G, I) Heatmaps of fold changes for diﬀerentially expressed genes (increased or decreased expression without any fold-change
threshold applied) highlighting sub-clusters that are speciﬁcally regulated by gata4. Abbreviations: control, uninjected explant; G4MO, G5MO, G6MO and 456MOs representing
respectively gata4, gata5, gata6 and all three combined morpholinos. Genes in sub-clusters 1 and 2 are listed in Fig. S1B, C.
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Here, we sought to increase our knowledge of the roles of these
factors in cardiomyogenesis (and consequently our knowledge of the
cardiogenic GRN) by identifying their respective transcriptionally
regulated genes on a genome-wide scale through RNA-seq analysis.
We have used our established cardiogenic assay (Afouda, 2012; Afouda
and Hoppler, 2009) of Xenopus laevis stem cell-like explants combined
with gene knockdown to identify genes that are diﬀerentially aﬀected
by each of the cardiogenic gata genes. By taking advantage of the recent
release of X. laevis genome assemblies and annotations (Xenbase.org:
(Karpinka et al., 2015)) we have identiﬁed and then validated sox7 and
sox18 as genes speciﬁcally regulated by gata4 in cardiomyogenesis.
Our genome-wide transcriptomics analysis therefore identiﬁes within
the GRN for cardiomyogenesis a conserved gene regulatory axis from
gata4 to the SoxF paralog genes sox7 and sox18 and further to heart
muscle cell diﬀerentiation. Our identiﬁcation of genes that are diﬀer-
ently regulated by each of cardiogenic gata factors also provides a
platform for future investigations that will further contribute to
elucidating of molecular pathways and the GRN underpinning em-
bryonic cardiomyogenesis.
2. Results
2.1. Xenopus stem-cell-like explants represent a reliable experimental
model system for analysis of cardiogenic diﬀerentiation
Xenopus animal cap cells represent a pluripotent stem-cell-like
tissue (Buitrago-Delgado et al., 2015) that can be induced to diﬀer-
entiate into various cell lineages by the addition of active inducer
protein into the culture medium (Asashima et al., 2009) or by prior
injection of inducer mRNA (Afouda, 2012; Warkman and Krieg, 2007;
Weber et al., 2000). We have developed a reliable cardiomyogenesis
assay consisting of injecting a low amount of Activin mRNA into animal
cap embryonic explants (subsequently called cardiac explants, Afouda
and Hoppler, 2009; Afouda et al., 2008). A myl2–green ﬂuorescence
(GFP) reporter line (myl2 is encoding myosin light chain 2, MLC2),
which faithfully recapitulates the expression of this marker in cardio-
myocytes (Latinkic et al., 2004) was used to show that explants from
such embryos not only diﬀerentiate into rhythmically beating tissues
and further allowed lineage tracing of cardiomyocytes and pan-
myocardial expression of myl2 (Fig. 1A, B and suppl movie 1). The
observed widespread expression of myl2 throughout each explant; and
functional beating of essentially the entire explant implies that most of
this tissue undergoes cardiac diﬀerentiation. This result demonstrates
that our experimentally accessible cardiogenic model system is ideal for
investigating the speciﬁc functions of cardiogenic gata factors in
relative isolation from their other functions in other embryonic tissues.
These advantages combined with the abundant amount of material
available from each explant make this assay ideal for high-throughput
sequencing approaches.
Supplementary material related to this article can be found online
at http://dx.doi.org/10.1016/j.ydbio.2017.11.017.
2.2. Transcriptomics screen for gata4-, gata5- or gata6-regulated
genes
We used this Xenopus stem-cell-like explant system to investigate
at a genome-wide scale which genes are speciﬁcally regulated by
diﬀerent cardiogenic gata factors during cardiomyogenesis.
Previously validated Morpholinos (MO) designed to knock down
(inhibit) gata4, gata5, or gata6 expression were used (Afouda et al.,
2005; Haworth et al., 2008; Peterkin et al., 2007). The eﬃcacy of the
gata MOs was further conﬁrmed by observing altered inactive tran-
script isoforms in samples where splice MOs were injected (Fig. S1A).
We prepared cultures of control cardiac explants, and cardiogenic
explants with single gata4, gata5, or gata6 knockdown and with a triple
gata4, 5, and 6 compound knockdown. We collected mRNA samples at
stage 32 for subsequent RNA-seq analysis. Before sequencing, collected
samples were validated for cardiac diﬀerentiation using quantitative
RT-PCR (Taq man assay, Peterkin et al., 2003) by monitoring expres-
sion of terminal diﬀerentiation markers such as myl2 and tnni3
(encoding cardiac Troponin I, TnIc) (Fig. 1C, D). As expected, we
observed reduced expression of these genes compared to control
samples in single gata knockdowns, and a stronger reduction in the
triple gata knockdown samples. Samples of mRNA from at least three
validated independent biological experiments each were used for high-
throughput sequencing (see M&M). Sequenced transcripts were
identiﬁed by mapping to genes in the genome (X. laevis genome,
version 9.1, Session et al., 2016), and counted to reveal expression
diﬀerences between experimental samples [Fig. 1E and Materials and
Methods; (Kim et al., 2015; Liao et al., 2014; Love et al., 2014)].
Threshold limits of two-fold diﬀerence in expression levels and
statistical signiﬁcance of 95% were chosen to assemble lists of
diﬀerentially expressed genes (Fig. 1F, H; and Table 1 sheet 1 and
Table 2 sheets 1 and 2 in Afouda et al., 2017). The chosen criteria were
validated by conﬁrmation that, as expected, expression of known
cardiac diﬀerentiation markers, such as myl2 and tnni3, were identiﬁed
as strongly reduced.
Using the above-mentioned bioinformatics strategy and criteria for
the transcriptome-wide analysis to identify gata-dependent genes we
found that expression of 1480, 1556 and 980 genes are decreased by
either single gata4, gata5 or gata6 knockdown, respectively (Fig. 1F).
Among these, 361 are speciﬁcally reduced by only the gata4 knock-
down, 547 speciﬁcally by the gata5, 165 speciﬁcally by the gata6 single
knockdown, while 529 genes are shared as they are reduced by either
gata4, gata5, or gata6 knockdown (Fig. 1F; and Table 1 in Afouda
et al., 2017). Overall 2834 genes are aﬀected by the triple gata4, gata5
and gata6 knockdown, of which 962 are only reduced in this triple
knockdown (Table 2 in Afouda et al., 2017). This genome-wide analysis
of the requirements for gene regulation of the cardiogenic gata
transcription factor genes gata4, gata5 and gata6 conﬁrms that they
have shared, redundant but also gene-speciﬁc functions during cardi-
omyogenesis.
2.3. sox7 and sox18 are among genes speciﬁcally regulated by gata4
during early cardiomyogenesis
Because of the potency of gata4 to promote cardiomyogenesis (see
above) we started here to focus on genes speciﬁcally aﬀected by the
gata4 knockdown. We proceeded with analysing gene ontology (GO)
terms associated with gata4-regulated genes (Fig. 1F; and see Afouda
et al., 2017, Table 3 sheet 3 for all 1480 genes aﬀected by gata4
knockdown and Table 3 sheet 4 for the 361 genes specially aﬀected by
the gata4 knockdown). Among the GO terms associated with genes
requiring gata4 functions are the GO terms “regulation of transcrip-
tion” and “DNA binding” (see Table 3 in Afouda et al., 2017),
suggesting that the gata4 gene is required during cardiomyogenesis
for regulating expression of other DNA-binding transcription factor
genes. Among those speciﬁcally reduced by lack of gata4 we discovered
two paralogs of the SoxF family, sox7 and sox18 (see Afouda et al.,
2017, Table S3 sheets 1 and 2, highlighted in red). Interestingly, SoxF
family members have been associated with cardiovascular development
in diﬀerent vertebrate species (reviewed by Francois et al., 2010), and
in Xenopus laevis sox7 and sox18 are essential for heart development
(Zhang et al., 2005b). We therefore decided to pursue this potential
regulatory axis involving gata4 and SoxF genes in cardiomyogenesis. In
order to test such a link further unsupervised clustering of our
transcriptome data was carried out (Fig. 1G, I). Again sox7 and
sox18 were contained in sub-clusters that are speciﬁcally aﬀected by
the gata4 knockdown (Fig. 1G, I and Fig. S1B, C). Together, our
transcriptomics analysis identify sox7 and sox18 as genes speciﬁcally
regulated by gata4 during early cardiomyogenesis.
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2.4. Temporal progression from gata4 to sox7 and sox18 expression
during cardiomyogenesis
The above data suggest that sox7 and sox18 expression in early
cardiomyogenesis is downstream of gata4 function and therefore
predicted to be after gata4 expression in development. Cardiogenic
explants were collected at various time points of development and gene
expression analysed by RT-PCR. In mouse, Mesp1 has been identiﬁed
as an early marker for cardiovascular progenitors and more impor-
tantly as a master regulator of cardiomyogenesis (Bondue and
Blanpain, 2010; Bondue et al., 2008; David et al., 2008). In Xenopus,
mespa has been shown to be the functional homologue of mammalian
Mesp1 (Kriegmair et al., 2013). We foundmespa and its paralogmespb
induced in cardiogenic explants from gastrulation onwards (Fig. 2).
gata4 as well as isl1 (marker for undiﬀerentiated but committed
cardiac precursors in this context, Pandur et al., 2013) are induced
early, mostly preceding expression of sox7 and sox18, followed by
expression of structural and diﬀerentiation markers myl2 and tnni3
(Fig. 2).
To test the requirement for sox7 and sox18, we experimentally
knocked down their expression with previously validated MOs (Zhang
et al., 2005b). sox7 or sox18 knockdown caused no loss of early marker
gene expression (mespa,mespb, gata4 and Isl1) but had a strong eﬀect
later on expression of diﬀerentiation markers (myl2 and tnni3) (Fig. 2).
These observations further conﬁrm that the explants recapitulate the
cardiogenic development and place sox7 and sox18 temporally down-
stream of gata4 and functionally upstream of cardiomyocyte diﬀer-
entiation.
2.5. sox7 and sox18 are required downstream in gata4-induced
cardiomyogenesis
In order to test for the ability of gata4 to induce sox7 and sox18
expression during cardiomyogenesis we used the previously established
cardiogenic assay in animal cap explants driven by a hormone
inducible gata4 (Afouda et al., 2008; Latinkic et al., 2003). All three
cardiogenic gata factors are capable of inducing heart diﬀerentiation
marker gene expression in this assay, but clearly to diﬀerent extents,
with only gata4 being able to drive diﬀerentiation into functionally
beating cardiomyocytes (Afouda and Hoppler, 2011). We found that
these diﬀerences are correlated with our ﬁnding that only gata4 is able
to induce sox7 and sox18 expression in this assay (Fig. 3A). This result
suggests that induction of beating cardiomyocytes by gata4 might
involve these two paralogs of the SoxF family.
Fig. 2. sox7 and sox18 are required for Activin-induced cardiac diﬀerentiation. Semi-quantitative RT-PCR assay monitoring cardiogenic gene expression (as indicated) in animal cap
explants injected with Activin alone or in combination with sox7 and sox18 MOs, analysed at control stages 13, 25 and 32. Note that pronounced sox7 and sox18 expression starts after
expression of cardiac progenitor markers mespa, mespb, and the early cardiac marker gata4. Note also that MO-mediated knockdown of sox7 or sox18 aﬀect cardiac diﬀerentiation, as
monitored by induction of cardiac diﬀerentiation markers myl2 and tnni3. M, Molecular size marker; control, uninjected explant; CoMO, control MO; 7MO, sox7 MO; 18MO, sox18MO;
W/E, whole embryo; odc, ornithine decarboxylase (internal loading control).
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We therefore addressed the question whether these SoxF genes are
required for gata4 to induce functional cardiomyocyte diﬀerentiation
(see also (Zhang et al., 2005b)). To this end, we knocked down sox7
and sox18 in gata4-induced cardiomyogenesis and monitored expres-
sion of the cardiac diﬀerentiation markers myl2 and tnni3 (Fig. 3B, C).
sox7 or sox18 knockdown causes substantially reduced cardiac diﬀer-
entiation as monitored by reduced expression of marker genes (Fig. 3B,
C). Importantly we had made certain that the exogenously over-
Fig. 3. sox7 and sox18 are required downstream of gata4 for cardiac diﬀerentiation. Semi-quantitative (A, B, D, F and H) and quantitative RT-PCR (C, E, G and I) assay monitoring
cardiac diﬀerentiation marker gene expression in control stage 32 explants. Explants injected with 1000 pg of mRNA encoding dexamethasone-inducible gata4 (G4GR), gata5 (G5GR)
and gata6 (G6GR) (A, B and C); or Activin-induced cardiac explants in the presence of control, sox7, sox18 or both SoxF MOs with mRNA encoding dexamethasone-inducible gata4, 5, 6
(D to I). Note that gata4, 5 and 6 induce cardiac diﬀerentiation to a diﬀerent extent (A). Note also that both sox7 and sox18 MOs result in reduced induction of cardiac diﬀerentiation
markers (myl2, tnni3) (B to I and that this cannot be recovered by overexpression of either gata4 or the other paralogs gata5 or 6 (D to I)). Note further that simultaneous knock down of
sox7 and sox18 essentially abolishes expression of cardiac diﬀerentiation markers (B, C, F and G) and that neither sox7 nor sox18 is required for their own or each other's expression (D,
F). CoMO, control MO; 718MOs, sox7 and sox18 MOs; Dex, Dexamethasone added at control stage 8 apart H and I as indicated at stages 8 and 13. Other abbreviations are as in Fig. 2.
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expressed protein is eﬃciently synthesised in the presence of the MOs
providing evidence that the observed eﬀect is due to the intrinsic
activity of GATA4 and its regulatory relationship with sox7 and sox18
(Fig. S1D). Our results show that sox7 and sox18 function is required
downstream of gata4 for induction of functional cardiomyocyte diﬀer-
entiation.
In our eﬀort to establish the epistatic functional relationship of
gata4 with sox7 and sox18 during cardiac diﬀerentiation we next
reinstated gata factor gene expression in a temporally controlled
manner in Activin-induced cardiac explants in which sox7 and sox18
function was knocked down. To this end we used the same hormone-
inducible version of gata4 (as introduced above and previously
described in Afouda et al., 2005; Afouda and Hoppler, 2011; Afouda
et al., 2008).
Induction of cardiomyogenesis was severely aﬀected by knockdown
of either sox7 or sox18, as measured by expression of terminal
diﬀerentiation markers myl2 and tnni3 (Fig. 3D, E); and cardiomyo-
genesis could not be restored by experimentally over-activating gata4
function. Our data conﬁrm the requirements for both paralogs of SoxF
family downstream of gata4 function during cardiomyocyte diﬀerentia-
Fig. 4. sox7 and sox18 are essential downstream mediators of gata4 during cardiomyogenesis. Activin-induced cardiac explants injected with control, gata4 or gata5 MOs together with
mRNA encoding inducible sox7 (7GR), sox18 (18GR) or gata proteins (G4GR, G5GR and G6GR), as indicated, which were activated before gastrulation (8, stage 8) (A to C) and during
late gastrula (13, stage 13), as indicated (D and E). Semi-quantitative (A, C and D) and quantitative (B and E) RT-PCR assay monitoring indicated markers analysed at control stage 32.
Note the partial recovery (A, B) of the eﬀect of gata4 inhibition on cardiac diﬀerentiation by experimentally activated SoxF proteins (7GR and 18GR). Note also that only gata4 knock
down aﬀects sox7 and sox18 expression and that only gata4 when reinstated can recover sox7 and sox18 expression. Note further the stage-dependent diﬀerent intrinsic cardiac inducing
properties of the three cardiogenic gata paralogs (as revealed by expression of cardiac diﬀerentiation markers myl2 and tnni3). Abbreviations are same as in previous ﬁgures. 200 pg and
1000 pg of mRNA were injected for overexpression of sox and gata proteins respectively.
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tion, which raises the question about possible redundancy between
these two factors.
To examine redundancy between sox7 and sox18 function, we
simultaneously knocked down both in cardiogenic explants and
proceeded with monitoring expression of cardiac diﬀerentiation mar-
kers (Fig. 3F, G), as well as functional diﬀerentiation (suppl movie 2
and Fig. S1E). Re-instating gata4 activity was unable to substantially
recover expression of marker genes for cardiogenic diﬀerentiation
(Fig. 3F, G). It is worth noting that neither sox7 nor sox18 knockdown
aﬀects their own or each other's expression. Additionally, reduced
cardiac diﬀerentiation in the sox7 knockdown (or sox18 knockdown,
data not shown) can also not be recovered by overexpression of either
gata5 or gata6 (Fig. 3H, I), conﬁrming that neither gata5 nor gata6
function downstream of sox7 (or sox18) function. As the amounts of
the gata proteins present after activation are comparable (Fig. S1F), we
can be certain that the observed eﬀects are due to the intrinsic potential
of each of these GATA factors in these experimental assays.
Supplementary material related to this article can be found online
at http://dx.doi.org/10.1016/j.ydbio.2017.11.017.
2.6. sox7 and sox18 can partially substitute for gata4 function during
cardiomyogenesis
We wondered to what extent SoxF function was able to mediate
gata4 function in cardiomyogenesis. In order to address this question
we developed an experimental design that would allow us to re-instate
sox7 or sox18 activity in a temporally controlled manner in a gata4
knockdown background. To this end we fused the sox7 and the sox18
coding sequence in frame with the ligand-binding domain of the
human glucocorticoid receptor (GR) (see Materials and Methods for
details). The obtained fusion construct called respectively sox7GR and
sox18GR were tested in animal cap explants and found to induce
expression of terminal cardiac diﬀerentiation markers myl2 and tnni3
(data not shown). Inhibition of gata4, as expected caused a clear
reduction of cardiogenic marker gene expression (cf. Afouda et al.,
2008); interestingly, marker gene expression is noticeably reinstated to
some extent when either sox7 or sox18 is experimentally activated
(Fig. 4A, B). As the eﬃciencies of the over-expressed sox7 or sox18
proteins are not aﬀected by the MOs (Fig. S1G), we can conclude that
sox7 or sox18 is able to induce expression of cardiac diﬀerentiation
markers when there is insuﬃcient gata4 function and that sox7 and
sox18 are therefore able to mediate some gata4 function during cardiac
diﬀerentiation.
2.7. The gata4-soxF regulatory axis mediates non-redundant
functions of cardiogenic gata factors in early versus later
cardiomyogenesis
The aim of this investigation was to identify speciﬁc functions for
the cardiogenic gata genes in the GRN driving vertebrate cardiomyo-
genesis. We had previously discovered non-redundant functions for
gata4 and gata5 (Afouda and Hoppler, 2011), brieﬂy with gata4
required for earlier and gata5 for later stages of cardiomyogenesis.
Our transcriptomics analysis here has now identiﬁed the SoxF genes
sox7 and sox18 as speciﬁcally regulated by gata4 (Fig. 1) and the above
experiments conﬁrm a functional role for sox7 and sox18 downstream
of gata4 during cardiomyogenesis (Figs. 2–4A, B). We therefore
wondered to what extent sox7 and sox18 function ﬁts with this concept
of early versus late functions of cardiogenic gata factors during
cardiomyogenesis and therefore particularly focussed here on gata4
and gata5. In addition, to avoid the supplied exogenous GATA mRNAs
being targeted by the MOs we have here used the previously validated
splice MOs to strictly target endogenous gata4 and gata5 (Afouda and
Hoppler, 2011; Haworth et al., 2008).
In the gata4 knockdown, as expected we observe strongly reduced
expression of early cardiac markers such as tbx5 and of both sox7 and
Fig. 5. sox7 and sox18 are required for endogenous cardiac diﬀerentiation in vivo. Semi-quantitative (A) and quantitative (B) RT-PCR analyses of cardiac diﬀerentiation (myl2
expression) in Xenopus stage 32 dorsal marginal zone (DMZ) explants injected with sox7 MO together with 200 pg of mRNAs encoding dexamethasone-inducible gata proteins, as
indicated. Note considerable requirement of sox7 function for cardiac diﬀerentiation (myl2 expression) and the ability of experimentally activated gata4, 5 or 6 to cause only a partial
recovery of cardiac diﬀerentiation in a sox7 knockdown (compare with Activin-induced cardiomyogenesis, see Fig. 3H and I). (C - G) Whole-mount in situ hybridisation analysis of tnni3
expression of stage 32 embryos which are either uninjected (C) or had been injected at the four-cell stage in the two dorsal blastomeres with sox7 MO (D), sox7 MO plus gata4GR mRNA
(E), sox18 MO (F) or sox18 MO plus gata4GR mRNA (G). Dexamethasone was added at stage13 to activate the inducible gata4 protein (in E and G). Note that embryos with depleted
sox7 and sox18 have reduced tnni3 expression compared to wild type (C) ranging from weak to complete reduction (D and F), which cannot be recovered with activated gata4 proteins (E
and G). (H) Quantiﬁed data of tnni3 expression in each condition.
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sox18; and —presumably as a consequence— of cardiac diﬀerentiation
markers such as myl2; all of which could be fully recovered with
experimentally reinstated gata4 function (Fig. 4C). In contrast inhibition
of gata5, as expected only aﬀects the later stage diﬀerentiation marker
myl2 but neither sox7 nor sox18 expression; nor early stage cardiac
markers (Fig. 4C). Interestingly reinstating gata5 activity could substan-
tially reinstate the expression of the diﬀerentiation marker myl2. These
observations conﬁrm that gata5 function during cardiomyogenesis is
sox7- and sox18-independent, in contrast to its paralog gata4.
We then decided to explore to what extent the other cardiogenic
gata factors gata5 and gata6 could replace gata4 in the regulation of
sox7 and sox18 during cardiomyogenesis. We conducted experiments
in which gata4 function was knocked down while concomitantly re-
instating gata4; or activating overexpressed gata5 or gata6, instead. We
discovered that in such an experimental setting, reduced expression of
sox7 and sox18 as well as of the cardiac diﬀerentiation markers myl2
and tnni3 could be recovered, as expected, when gata4 was reinstated,
either at stage 8 or stage 13; but experimentally activated gata5 or
gata6 could only recover expression of diﬀerentiation markers but
neither sox7 nor sox18 (Fig. 4D, E). Our data show that only gata4
regulates sox7 and sox18 during cardiomyogenesis and that the other
cardiogenic gata factors gata5 and gata6 cannot compensate for gata4
in this assay and must therefore here function via sox7- and sox18-
independent mechanisms.
Fig. 6. Sox7 is required during mouse ES cell diﬀerentiation into cardiomyocytes (A) RT-qPCR analysis of Gata4 expression at day 5 (D5) of cardiomyocyte diﬀerentiation. Gata4
expression was signiﬁcantly decreased in cells transfected with Gata4 shRNA compared to control cells. (B) Tnnt2 expression was decreased at D10 in Gata4 knockdown cells compared
to untransfected controls. (C) Sox7 expression during cardiomyocyte diﬀerentiation. At D5, Sox7 expression was reduced in cells transfected with Gata4 shRNA compared to controls,
though at subsequent stages expression was increased. (D) Sox18 expression was also reduced at D5 in cells transfected with Gata4 shRNA compared to untransfected controls, whereas
expression was increased during later stages of diﬀerentiation. (E) RT-qPCR analysis of Sox7 expression in inducible Gata4 (iGata4) mouse ES cells. Following doxycycline (+dox)
induction at D4, Sox7 was rapidly upregulated at D5 compared to control (-dox). (F and G) RT-qPCR analysis of Sox7 expression in iGata5 and iGata6 cells. Sox7 expression was only
moderately increased at D5 in induced cells compared to iGata4 (E). Sox7 expression was later increased at D7 and D10 compared to controls. (H) RT-qPCR analysis of Sox18 in iGata4
cells. Sox18 expression was only slightly increased at D5 following doxycycline induction at D4, compared to uninduced controls. (I and J) RT-qPCR analysis of Sox18 expression in
iGata5 and iGata6 cells. Sox18 expression was increased at D5 following doxycycline induction at D4 in iGata5 and iGata6 cells, compared to uninduced controls.
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2.8. sox7 and sox18 are required for heart muscle diﬀerentiation in
the embryo
Activin-induced cardiac explants are good for studying cardiomyo-
genesis in relative isolation from neighbouring embryonic tissues and
therefore for studying cardiogenic gata and SoxF function speciﬁcally
in cardiogenic mesoderm. Dorsal marginal zone (DMZ) explants
diﬀerentiate into heart tissue in the absence of added factors (Foley
and Mercola, 2005; Schneider and Mercola, 2001), presumably be-
cause the cardiac precursors reside within this part of intact gastrulat-
ing Xenopus embryos (Afouda and Hoppler, 2009). These DMZ
explants therefore represents a ﬁrst step in putting the cardiogenic
tissue back into the normal wider embryonic context. We conducted
similar experiments using DMZs to those described above with Activin-
induced cardiac explants (cf. Fig. 3H). DMZs in which sox7 is knocked
down (or sox18, data not shown) have reduced cardiac diﬀerentiation
marker gene expression as measured by semi-quantitative and quanti-
tative RT-PCR (Fig. 5A, B). Interestingly when any one of the
cardiogenic gata factors is activated we observe a noticeable recovery
of cardiomyogenesis, which is diﬀerent from what had been observed
above in Activin-induced cardiogenic explants (cf. Fig. 3H). This
observation suggests existence of endogenous tissues or factor(s) in
DMZ explants that are not present within Activin-induced cardiac
explants, which allow the paralogs gata5 and 6 to reinstate cardiac
diﬀerentiation even in a sox7 (or sox18) knock down.
As a further step for putting the cardiogenic tissue back into the
normal embryonic context we studied a whole embryo sox7 knockdown
or sox18 knockdown by targeting injection of sox7 or sox18 MOs into
the prospective heart tissue of 4-cell stage Xenopus embryos (Afouda
et al., 2008; Foley and Mercola, 2005; Martin et al., 2010; Nascone and
Mercola, 1995; Sater and Jacobson, 1990). Although mixed phenotypes
were observed, there is a reduction of expression of the myocardium
diﬀerentiation marker tnni3 in the sox7 or the sox18 knockdown
(Fig. 5C-H). Additionally we found no diﬀerence between those
knockdown embryos and knockdown embryos in which gata4 activity
has been experimentally activated (Fig. 5E, G). We therefore conclude
that sox7 and sox18 are required for normal myocardium diﬀerentia-
tion in a manner consistent with functioning downstream of gata4
during cardiac diﬀerentiation.
2.9. Sox7 regulation by Gata4 is conserved in mammalian
cardiomyogenesis
Molecular pathways involved in cardiomyogenesis are generally
well conserved among vertebrates (Bruneau, 2002; Zaﬀran and Frasch,
2002). In order to test for conservation in mammalian cardiomyogen-
esis of the proposed Gata4 to Sox7/Sox18 regulatory axis we used
mouse Embryonic Stem Cells (mESCs) cultured as Embryonic Bodies
(EBs) that spontaneously undergo cardiomyocyte diﬀerentiation
(Boheler et al., 2002). We conﬁrmed that Gata4 (Fig. 6A), the
cardiomyocyte diﬀerentiation marker Tnnt2 (Fig. 6B), Sox7 (Fig. 6C)
and Sox18 (Fig. 6D) are expressed in these EBs. In a Gata4 shRNA
knockdown (Fig. 6A-D), expression of Sox7 and Sox18 are reduced
(Fig. 6C, D), as is the expression of Tnnt2 (Fig. 6B). This conﬁrmed the
Gata4 requirement for normal Sox7 and Sox18 expression during
cardiomyocyte diﬀerentiation. In order to test for the ability of
cardiogenic Gata factors to regulate Sox7 and Sox18 expression, we
used mESC lines in which the expression of individual cardiogenic gata
factors can be experimentally activated (iGata4, iGata5, iGata6,
Turbendian et al., 2013). Experimental activation of Gata4 expression
prompted a quick and dramatic induction of Sox7 expression (Fig. 6E).
Other cardiogenic Gata factors were only able to cause a much more
modest initial induction of Sox7 expression (iGata6, Fig. 6G) or only a
delayed response (iGata5 and iGata6, Fig. 6F, G), suggesting indirect
mechanisms. In contrast, experimental overexpression of Gata4 caused
only a slight increase in Sox18 expression (Fig. 6H), whereas ectopic
expression of Gata5 and Gata6 cause a greater increase in Sox18
expression (Fig. 6I, J). These ﬁndings suggest that regulation by Gata4
of the SoxF genes Sox7 and Sox18 is conserved in the context of
mammalian cardiomyogenesis. However, in contrast to animal caps,
we ﬁnd that Sox18 is regulated by all three cardiogenic Gata factors in
EBs (Fig. 6I-J).
3. Discussion
Wnt/β-catenin signalling can inhibit early cardiomyogenesis (e.g.
Ueno et al., 2007), which we discovered is mediated by negative
regulation of gata gene expression (Afouda and Hoppler, 2009;
Afouda et al., 2008; Martin et al., 2010). Our subsequent studies had
additionally discovered some speciﬁc functional requirements of
diﬀerent cardiogenic gata factor genes for cardiomyogenesis (Afouda
and Hoppler, 2011). In this study we aimed to explore such gata gene-
speciﬁc functions more comprehensively using genome-wide transcrip-
tomics analysis, in order to widen our general understanding of the
gene regulatory network (GRN) directing cardiomyogenesis. Using
gene knockdown approaches we have identiﬁed genes that are speci-
ﬁcally regulated by individual cardiogenic gata factor genes gata4,
gata5 or gata6; as well as those regulated by either one of them, and
those regulated by all three of them together.
We are here focussing only on some aspects of the wealth of
information that was generated in our high-throughput sequencing
experiments, especially on genes speciﬁcally regulated by gata4. Gene
ontology (GO) analysis suggests that gata4 tends to regulate other
transcription factor genes during cardiomyogenesis, among which we
identiﬁed the SoxF subfamily genes sox7 and sox18 (Fig. 1). This
requirement of speciﬁcally gata4 for sox7 and sox18 expression is
conﬁrmed in subsequent validation experiments (e.g. Fig. 4), which
also demonstrate that re-instating gata4 is capable of recovering sox7
—and to some extent sox18— expression. Mammalian Sox7 expression
also requires Gata4 function in a mouse ESC model of cardiomyogen-
esis, where Gata4 is also uniquely capable of promptly inducing Sox7
expression (Fig. 6). The discovery that this SoxF gene is also down-
stream of Gata4 in our mouse ES cell model strongly validates our
Xenopus data and furthermore demonstrates that molecular pathways
involved in early vertebrate cardiomyogenesis tend to be conserved. We
conclude that we have identiﬁed an important gene regulatory axis
from gata4 to SoxF family of transcription factors in heart muscle
diﬀerentiation.
This gata4-SoxF regulatory axis is, however, only part of a much
wider gata gene-mediated GRN for cardiomyogenesis. Future experi-
ments will be required to explore other gata4-regulated candidate
genes identiﬁed by our transcriptomics analysis (and those regulated
by gata5 and gata6, see Fig. 1; and Table 1 in Afouda et al. (2017)),
and to determine whether the transcriptional regulation of sox7 and
sox18 by GATA4 is direct or involves important yet unidentiﬁed
intermediary factors. It is expected that gata4 function in cardiomyo-
genesis involves other downstreammediators, since the sox7 and sox18
knockdown phenotype is less severe then the gata4 knockdown (Fig. 2)
and also since experimentally reinstating sox7 and sox18 function
cannot fully recover cardiomyogenesis in a gata4 knockdown (Fig. 4).
Identiﬁcation of such key genes downstream of gata4 and of other
cardiogenic gata genes promises to provide a better understanding of
human cardiomyopathies resulting from GATA4mutations (Garg et al.,
2003; Rajagopal et al., 2007) and mouse phenotypes such as acardia in
Gata4 and Gata6 double mutant embryos (Zhao et al., 2008).
An important role for SoxF genes for cardiovascular development is
further supported by the cardiovascular failure of mice lacking Sox7
that leads to death of embryos at embryonic day 10.5 (Wat et al., 2012),
by the importance of Sox7 in arterial speciﬁcation (Hermkens et al.,
2015) and by the essential functions of sox7 and sox18 in Xenopus
cardiomyogenesis (Zhang et al., 2005b). Our data indicates possible
redundancy between sox7 and sox18 as knockdown of both together
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leads to a more severe reduction of cardiac marker gene expression
than either of them alone (Fig. 3) (see also Zhang et al., 2005b).
However, there are also SoxF-independent regulatory mechanisms
expected to drive cardiomyogenesis. It is intriguing that although gata5
and gata6 are not able to reinstate sox7 or sox18 expression in a gata4
knockdown, they can substantially reinstate expression of cardiac
diﬀerentiation markers (Fig. 4). This suggests sox7- and sox18-
independent pathways downstream of gata5 and gata6 (Fig. 7). This
conﬁrms our and other previous studies (Afouda and Hoppler, 2011;
Ieda et al., 2010) uncovering divergent functional roles of cardiogenic
GATA factors during cardiomyogenesis. Our discovery of sox7 and
sox18 as genes speciﬁcally regulated by gata4 not only increases our
general understanding of cardiogenesis but also provides speciﬁcally
insights into the gene regulatory mechanisms involved. Functional
interactions with other regulators of cardiogenesis are likely, for
instance, SOX proteins have previously been shown to interact with
β-catenin (Kormish et al., 2010; Zorn et al., 1999), which can function
as an inhibitor during early cardiogenesis (Afouda et al., 2008; Ueno
et al., 2007). However, further studies have shown that while SOX7
physically interacts with β-catenin and functionally inhibits Wnt
signalling pathway activity; a version of SOX7 that cannot interact
with β-catenin is still able to induce cardiogenesis (Zhang et al., 2005b)
suggesting that this aspect of Sox7 function in cardiogenesis is Wnt/β-
catenin-independent. Since sox7 and sox18 have been reported to
induce the expression of nodal4, nodal5 and nodal6 in cardiogenesis in
Xenopus explants (Zhang et al., 2005a, 2005b) we include them in a
model to depict the functional diﬀerences between gata paralogs during
cardiomyogenesis (Fig. 7).
It is also the wider embryonic context with neighbouring tissues
that provides further dependability and built-in redundancy to the gene
regulatory mechanisms driving cardiomyogenesis. While studying
cardiogenesis in relative isolation in Activin-induced cardiac explants
was eﬀective for uncovering the gata4-SoxF regulatory axis (Fig. 3), the
wider embryonic context of DMZ explants suggests that there are
additional pathways allowing all cardiogenic gata factors to relieve
inhibition of cardiac diﬀerentiation in the sox7 knockdown (Fig. 5A, B).
Future experiments will need to explore any role particularly for the
endoderm: it is intriguing for instance that we observe a further loss of
expression of cardiomyocyte diﬀerentiation markers in the sox7 knock-
down (Fig. 3H, I), and of earlier cardiac progenitor markers such as
mespa (data not shown), when cardiogenic GATA function is experi-
mentally activated during early stages, which could be explained by the
pro-endoderm-inducing activity of these GATA factors (Afouda et al.,
2005). In support, we do observe a slight increase in the induction of
the third SoxF paralog sox17α, a known endoderm marker (data not
shown). A role of the endoderm for cardiomyogenesis in the wider
embryonic context is of course consistent with the previously proposed
requirements of signals from this layer for cardiac development (Foley
et al., 2007; Foley and Mercola, 2005; Liu et al., 2014; Nascone and
Mercola, 1995, 1996; Schneider and Mercola, 2001).
In conclusion, our results identify an important gene regulatory axis
from gata4 to the SoxF paralogs sox7 and sox18 for heart muscle
diﬀerentiation, which is conserved in wider embryonic contexts (DMZ
and entire embryo, Fig. 5) and in mammalian cardiomyogenesis
(Fig. 6). Our ﬁndings represent a further important advance in the
molecular dissection of the regulatory mechanisms controlling heart
formation. They pave the way for further investigations into elucidating
GRNs that are involved downstream of gata4 and the other paralogs
gata5 and gata6 in heart muscle development.
4. Materials and methods
4.1. Ethics statement
All Xenopus experiments were performed according to the
University of Aberdeen's Code of Practice on the Use of Animals in
Research as well as the legal requirements of the Animals (Scientiﬁc
Procedures) Act 1986 (Licence PPL 60/4376) and the Home Oﬃce
Code of Practice guidance.
4.2. Expression constructs, mRNA synthesis and morpholinos
Activin β B, gata4GR, gata5GR and gata6GR DNA constructs for
mRNA synthesis have been described previously (Afouda et al., 2005,
2008; Afouda and Hoppler, 2011). Xenopus laevis sox18GR DNA
construct was made by in frame fusion of its coding region to the region
encoding the hormone-inducible domain of human gluco-corticoid
receptor in pSP64T-GR as previously described (Tada et al., 1997).
To this end, a BamHI site was created at the end of the ampliﬁed
coding sequence and inserted into BglII-digested vector. The following
primer sequences were used to amplify Xenopus laevis sox18
(pDONR223Xsox18 a kind gift from Prof Aaron Zorn and Scott
Rankin). Xsox18: 5′ GGA TCG GAT CCA CCA GGA TGC ATA GAT
CTA GC 3′ for the forward primer and 5′ GAT CCG GAT CCC TAG CCA
GTA ATA CAG GGG 3′ for the reverse primer (accession number NM_
001088635). The Xenopus laevis sox7 fusion construct (Xsox7GR) was
made from stage 32 cardiac explants cDNA synthesised according to a
previously described protocol (Weber et al., 2000). To this end we’ve
designed speciﬁc primers to sox7 sequence accession number NM_
001085868 ﬂanked by BglII sequence to amplify its cDNA. The
following primers sequences were used: Xsox7: 5′ GGA TCA GAT
CTA CCA GGA TGA CTA CCC TGA TGG GAT CC 3′ for the forward
primer and 5′ GAT CCA GAT CTA GAA ACA CTA TAA CTG TTG 3′ for
the reverse primer. The PCR product was BglII-digested and inserted
Fig. 7. Proposed model to depict the functional diﬀerences between cardiogenic gata
paralogs during cardiomyogenesis. The SoxF paralogs sox7 and sox18 mediate gata4 but
not gata5 and gata6 function during cardiomyogenesis. All cardiogenic gata function
after induction of early cardiac transcription factors where sox7 and sox18 act down-
stream to mediate only some of gata4 but not gata5 and gata6 function during
cardiomyogenesis (for details, see text in Discussion Sections). ×1? and ×2? indicate
yet unidentiﬁed intermediary factors.
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in frame into pSP64T-GR vector as above. All the constructs were
checked by restriction digestion and by sequencing. All fusion plasmids
were SalI-linearized and in vitro transcribed with SP6 using
mMESSAGE mMACHINE kits (Ambion) according to the
manufacturer's instruction. The following amounts of RNA were
injected: 50 fg for Activin, 200–1000 pg for all other constructs per
embryo (see Figures legends). Xenopus gata4 splice morpholino, gata5
splice morpholino (Haworth et al., 2008), gata6 morpholino (Peterkin
et al., 2003), Xsox7 and Xsox18 (Zhang et al., 2005b) morpholinos
have been previously described. The amounts of MOs injected per
embryo are: 50 ng (gata4, 4MO), 8 ng (gata5, 5MO), 10 ng (gata6,
6MO), 30 ng for single (sox7, 7MO) and (sox18, 18MO) and 15 ng of
each when combined.
4.3. Embryos and explants culture
Xenopus laevis embryos were obtained as previously described
(Afouda et al., 2005). Embryos and explants culture as well as embryos
injection were as described in Afouda et al. (2008) and Afouda and
Hoppler (2011). Animal cap explants were excised as previously
described (Afouda, 2012) and where applicable dexamethasone was
added at ﬁnal concentration of 10 µM (at either stage 8 or 13, see
Figures legends) for activation of GR-fusion proteins. Live GFP beating
explants imaging was performed using ZEISS Axio Observer Z.1
microscope with the Axiovision software and movies were taken using
Leica M60 microscope mounted with Leica MC 170 HD camera.
Transgenic embryos were obtained from myl2-GFP lines. They were
sourced from National Xenopus Resource (at Marine Biology
Laboratory, Woods Hole, Massachusetts, USA) and were previously
generated (Latinkic et al., 2004).
4.4. RNA extraction, RNA expression analysis and protein analysis
Whole mount in situ hybridisation (WISH) was conducted as
previously described (Ciau-Uitz et al., 2000). A digoxigenin-labelled
RNA probe was prepared with T7 polymerase, using High Yield
Megascript Kit (Ambion) from NotI-linearized plasmid template for
tnni3 (Drysdale et al., 1994). The abundance of RNAs was determined
using semi-quantitative Reverse Transcriptase PCR (RT-PCR) (Afouda
and Hoppler, 2011) and real time quantitative Taq man assays using
the comparative CT method. For this, at least three repeats were done
for each experimental group and 20–30 cardiogenic explants were
analysed for each condition (or 25–50 mESC Embryoid Bodies). For
each experimental repeat measurements for each condition were
conducted in triplicate and relative mRNA expression levels were
calculated by normalisation to Xenopus odc or mouse Gapdh
mRNAs. Raw data were analysed with the ΔΔCT method (Livak and
Schmittgen, 2001). Data are mean ± SEM, n = 3, P ≤ 0.05. Data
presented are representative of one experiment. Reactions were run on
Abi 7700 Sequence Detector (Afouda et al., 2005; Peterkin et al., 2003).
Sequences of primers and probes for quantitative Taq man were as
described in (Peterkin et al., 2003). Sequence of primers used for semi-
quantitative RT-PCR are as follow: gata4, myl2, tnni3 and odc (Afouda
and Hoppler, 2011); Xenopus laevis mespa and mespb (Hitachi et al.,
2009); Xenopus laevis Isl1 (Gessert and Kühl, 2009); sox17α (Afouda
et al., 2005). For both sox7 and sox18 the primers used were designed
based on accession numbers mentioned above that are homeologs of
the ones identiﬁed in our RNA-seq results and are as follow: sox7
primers 5′ ATG ACT ACC CTG ATG GGA TCC TAC AGC 3′ for forward
primer and 5′ AGA AAC ACT ATA ACT GTT GTA GTA CG 3′ for reverse
primer and for sox18 5′ ATG CAT AGA TCT AGC TAC TGC AGA G 3′
for forward primer and 5′ GCC AGT AAT ACA GGG GGT ATA GTA C 3′
for reverse primer. Protein extraction and western blot analysis were as
previously described (Afouda et al., 2005).
RNAs were extracted from ES cells and Embryoid Bodies using the
Absolutely RNA Microprep Kit (Agilent) according to the manufac-
turer's instructions. cDNAs were prepared as previously described
(Afouda et al., 2005) and quantitative PCR was performed using
LightCycler 480 Probes Master Mix from Roche with Universal Probe
Library (UPL) and reaction run on LightCycler 480 machine.
4.5. RNA-seq experiments and analysis
At least 30 explants were used for RNA preparation with a
previously described protocol (Afouda and Hoppler, 2011; Afouda
et al., 2008). RNA quantity and quality were checked on electrophoretic
agarose gel, a fraction of which was used for validation with gene
expression analysis by quantitative RT-PCR (Afouda et al., 2005) to
conﬁrm expected increase or decrease of known control gene expres-
sion before RNA-seq sequencing. RNA was isolated from three
independent biological replicates for each condition. Illumina TruSeq
RNA libraries were constructed and sequenced on the Illumina
HiSeq_2500 platform at the Earlham Institute, Norwich Research
Park, Norwich, UK. 100 bp paired-end sequencing reads were aligned
to the Xenopus laevis genome (version 9.1) using HiSat2 (Kim et al.,
2015) and quantiﬁcation was done using featureCounts (Liao et al.,
2014). Diﬀerential expression analysis was performed using DESeq. 2
(Love et al., 2014) with an adjusted p value < 0.05. Diﬀerentially
expressed genes were identiﬁed using a threshold of log-2 fold change
> 1 (for at least two times increased) or < −1 (for at least two times
reduced) in comparison to Activin-induced Xenopus animal cap
cardiac explant controls. Analyses of diﬀerentially expressed genes
were performed using Partek genomics Suite 6.6. Similarly hierarchal
clustering was performed in Partek Genomic genomics Suite 6.6.
Counts were averaged for each condition and then these averages were
standardised to have the same mean across the diﬀerent conditions.
Similarity between each gene expression proﬁle within each cluster was
then computed with Euclidean distance and shown as heatmap
(Fig. 1G, I). For gene ontology (GO) analyses, GO classes containing
at least six genes were taken into consideration.
4.6. ES cell culture and diﬀerentiation
Inducible reporter Mesp1/Gata4 and iGata cell lines were obtained
from Professors Cedric Blanpain (Université Libre de Bruxelles,
Belgium, (Bondue and Blanpain, 2010)) and Todd Evans (Weill
Cornell Medical College, USA, (Holtzinger et al., 2010; Turbendian
et al., 2013)), respectively. Inducible Mesp1 cells were maintained and
diﬀerentiated as previously described (Bondue and Blanpain, 2010;
Bondue et al., 2008). The iGata4/5/6 cells were maintained and
diﬀerentiated as previously described (Holtzinger et al., 2010;
Turbendian et al., 2013), except that Embryoid Bodies were diﬀer-
entiated in hanging drop culture. shRNAs were obtained from Qiagen
and stable transfected cell lines were generated according to manufac-
turer's instructions.
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